PAX9 and Col1A1 may regulate the progression of colon cancer through interactions with the TGF-β1/Smad pathway

Chao Huang1, Bingjun Liang1, Weizeng Shen1

  • 1Department of Traditional Chinese Medicine, Shenzhen Hospital of Guangdong Provincial People's Hospital (The Second Affiliated Hospital of Shenzhen University), Shenzhen 518100, China.

Cytokine
|October 15, 2025
PubMed
Abstract

Insights

Transforming growth factor-β1 (TGF-β1) and its Smad pathway significantly impact colon cancer survival and stage. Key molecules like PAX9, VDR, and Col1A1 are implicated in its progression and prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transforming growth factor-β1 (TGF-β1) signaling via the Smad pathway is crucial in cancer progression.
  • The precise mechanisms linking TGF-β1/Smad pathway to colon cancer remain incompletely understood.

Purpose of the Study:

  • To investigate the relationship between TGF-β1/Smad pathway molecules and colon cancer progression.
  • To explore upstream and downstream regulatory mechanisms of this pathway in colon cancer.

Main Methods:

  • Utilized TCGA-COAD, GEO, and ENCODE databases for clinical and gene expression data.
  • Analyzed expression levels of TGF-β1, its receptor, and SMAD2/3/4 in colon cancer tissues.
  • Employed R packages for differential gene expression analysis and promoter binding site identification.
  • Used JASPAR and GO/KEGG for predicting transcription factors and downstream targets.

Main Results:

  • TGF-β1 expression levels significantly correlated with overall survival (OS) and disease-free survival (DFS) in 459 colon cancer patients.
  • Pathway molecule expression varied with cancer stage.
  • Identified 954 genes with Smad2/3 binding sites; PAX9 and VDR showed altered expression in colon cancer.
  • Col1A1 expression strongly correlated with TGF-β1 and was associated with survival outcomes.

Conclusions:

  • The TGF-β1/Smad pathway, along with target genes PAX9, VDR, and Col1A1, plays a role in colon cancer progression and prognosis.
  • Pathway activity is linked to cancer stage and survival, suggesting therapeutic potential.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.2K